[Chang 2016] – Chang, Jyh-Lurn, Montalto, B., M., Heger, W., P., et al.: Rheum rhaponticum Extract (ERr 731): Postmarketing Data on Safety Surveillance and Consumer Complaints, Integr Med (Encinitas), 06, 2016.
[Choi 2012] – Choi, Kyeong-Ok, Lee, I., Paik, Sae-Yeol-Rim, et al.: Ultrafine Angelica gigas Powder Normalizes Ovarian Hormone Levels and Has Antiosteoporosis Properties in Ovariectomized Rats: Particle Size Effect, J Med Food, 10, 2012.
[Hasper 2009] – Hasper, I., Ventskovskiy, M., B., Rettenberger, R., et al.: Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms, Menopause, 01-02, 2009.
[Heger 2006] – Heger, M., Ventskovskiy, M., B., Borzenko, I., et al.: Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial, Menopause, 09-10, 2006.
[Sowndhararajan 2017] – Sowndhararajan, K. and Kim, S.: Neuroprotective and Cognitive Enhancement Potentials of Angelica gigas Nakai Root: A Review, Sci Pharm., 28, 04, 2017.
[Wilson 2021] – Wilson, M., Konda, V., Heidt, K., et al.: Rheum rhaponticum Root Extract Improves Vasomotor Menopausal Symptoms and Estrogen-Regulated Targets in Ovariectomized Rat Model, Int J Mol Sci., 21, 01, 2021.
[Wober 2007] – Wober, J., Möller, F., Richter, T., et al.: Activation of estrogen receptor-beta by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds, J Steroid Biochem Mol Biol., 22, 06, 2007.